Methyl 4-(5-methyl-1,2,4-oxadiazol-3-yl)benzoate

Catalog No. :
ACNPGQ192
CAS No. :
196301-94-7
Molecular Formula :
C11H10N2O3
Molecular Weight :
218.21

IUPAC Name:methyl 4-(5-methyl-1,2,4-oxadiazol-3-yl)benzoate

Methyl 4-(5-methyl-1,2,4-oxadiazol-3-yl)benzoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$117.00Login to see priceInquiryInquiry
5g95%$253.00Login to see priceInquiryInquiry
25g95%$718.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 4-(5-methyl-1,2,4-oxadiazol-3-yl)benzoate
IUPAC Namemethyl 4-(5-methyl-1,2,4-oxadiazol-3-yl)benzoate
MDL No.MFCD12198877
Molecular FormulaC11H10N2O3
Molecular Weight218.21
SMILESO=C(OC)C1=CC=C(C2=NOC(C)=N2)C=C1
InChI KeyMBZDWMKGQVUJQD-UHFFFAOYSA-N
SynonymMethyl 4-(5-methyl-1,2,4-oxadiazol-3-yl)benzoate | 196301-94-7 | 4-(5-Methyl-[1,2,4]oxadiazol-3-yl)-benzoic acid methyl ester | MFCD12198877 | SCHEMBL13938063 | DTXSID70446850 | BCP32514 | WHA30194 | 4-(5-METHYL-1,2,4-OXADIAZOL-3-YL)BENZOIC ACID METHYL ESTER | AC5144 | AKOS0
CAS No.196301-94-7
PubChem CID10878612

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACNPGQ192 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACNPGQ192 route product structure diagram
    ACNPGQ192196301-94-7
Inquiry

2. ACNPGQ192 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. ACNMPF168 route compound structure diagram
    ACNMPF16895124-68-8 In Stock
  4. Then
  5. ACNPGQ192 route product structure diagram
    ACNPGQ192196301-94-7
Inquiry

Comments (0)